Job Description

Job Overview

The Senior Principal Scientist - Peptide Synthesis will lead the design, development, and optimization of peptide synthesis processes, driving innovation and contributing to the strategic direction of the peptides R&D program.

Key Stakeholders: Internal

Operations, Marketing, Quality, Finance, Sr. leaders

Key Stakeholders: External

Vendors and Customers on need basis

Reporting Structure

Functional reporting to Associate Director R&D

Experience

Minimum 10+ years of hands-on experience in peptide purification.

Competencies

Leadership skills Ability to connect the dots in various situations, seeing the risk and keep the mitigation plans. Clear communication. Analytical mindset. Quick and effective decision making. Stakeholder management.

Roles & Responsibilities

Develop and implement strategic plans for peptide research and development in alignment with organizational goals and objectives. Lead and manage peptide synthesis projects from inception to completion, ensuring timelines, budgets, and quality standards are met. Collaborate with process development and purification teams to ensure seamless integration of peptide synthesis into downstream processes. Drive innovation by exploring new techniques and technologies for peptide synthesis. Create the Innovative Research and Development Environment Train and guide the research teams to improve on developing/ adopting new chemical technologies. Support in driving positive & major EHS Cultural transformation Initiatives Take ownership of solvent recovery and yields improvement. Ensure compliance with regulatory guidelines and requirements governing peptide drug development and help the teams in successful regulatory inspection with no critical observations

In the three decades of its existence, Piramal Group has pursued a twin strategy of both organic and inorganic growth.
Driven by its core values, Piramal Group steadfastly pursues inclusive growth, while adhering to ethical and values-driven practices.

Equal employment opportunity

Piramal Group is proud to be an Equal Employment Opportunity and Affirmative Action employer. We do not discriminate based upon race, ethnicity, religion, color, national origin, gender (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, genetics, or other applicable legally protected characteristics.



We base our employment decisions on merit considering qualifications, skills, performance, and achievements. We endeavor to ensure that all applicants and employees receive equal opportunity in personnel matters, including recruitment, selection, training, placement, promotion, demotion, compensation and benefits, transfers, terminations, and working conditions, including reasonable accommodation for qualified individuals with disabilities as well as individuals with needs related to their religious observance or practice.

Piramal Pharma Solutions (PPS)

is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug products. PPS also offers development and manufacturing services for biologics including vaccines, gene therapies, and monoclonal antibodies, made possible through Piramal Pharma Limited's investment in Yapan Bio Private Limited. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovators and generic companies worldwide.